about
Recent mouse and rat methods for the study of experimental oral candidiasisEfficacy of nystatin for the treatment of oral candidiasis: a systematic review and meta-analysisAdvanced drug delivery systems for local treatment of the oral cavityPost-PKS tailoring steps of a disaccharide-containing polyene NPP in Pseudonocardia autotrophicaImportance of Diversity in the Oral Microbiota including Candida Species Revealed by High-Throughput Technologies.Saliva as a diagnostic fluid.In vitro activities of natural products against oral Candida isolates from denture wearers.Oral candidosis--clinical challenges of a biofilm disease.Licorice and its potential beneficial effects in common oro-dental diseases.Low-cost periodontal therapy.Human antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates.A novel antifungal is active against Candida albicans biofilms and inhibits mutagenic acetaldehyde production in vitro.Mucosal biofilms of Candida albicans.Novel Nystatin A₁ derivatives exhibiting low host cell toxicity and antifungal activity in an in vitro model of oral candidosis.Evaluation of gene expression SAP5, LIP9, and PLB2 of Candida albicans biofilms after photodynamic inactivation.Gold Nanoparticle-Photosensitizer Conjugate Based Photodynamic Inactivation of Biofilm Producing Cells: Potential for Treatment of C. albicans Infection in BALB/c MiceEpithelial cells and innate antifungal defense.Development and evaluation of N-naphthyl-N,O-succinyl chitosan micelles containing clotrimazole for oral candidiasis treatment.Photodynamic therapy of oral Candida infection in a mouse model.Divergent targets of Candida albicans biofilm regulator Bcr1 in vitro and in vivo.An In-vitro Evaluation of Retention, Colonization and Penetration of Commonly Used Denture Lining Materials By Candida albicansOral innate immunity in HIV infection in HAART eraSemi-interpenetrating network (sIPN) gelatin nanofiber scaffolds for oral mucosal drug deliveryFirst Description of Oral Cryptococcus neoformans Causing Osteomyelitis of the Mandible, Manubrium and Third Rib with Associated Soft Tissue Abscesses in an Immunocompetent Host.Local drug delivery for oral mucosal diseases: challenges and opportunities.Chronic invasive aspergillosis of paranasal sinuses: A case report with review of literature.Denture polymers with antimicrobial properties: a review of the development and current status of anionic poly(methyl methacrylate) polymers.Uncommon opportunistic fungal infections of oral cavity: A review.Opportunistic yeast pathogens: reservoirs, virulence mechanisms, and therapeutic strategies.Efficacy and safety of miconazole for oral candidiasis: a systematic review and meta-analysis.Novel strategies against Candida biofilms: interest of synthetic compounds.Disinfectants to Fight Oral Candida Biofilms.Comparison of the Antibacterial Properties of Three Mouthwashes Containing Chlorhexidine Against Oral Microbial Plaques: An in vitro Study.Application of the novel method in the diagnosis and treatment of median rhomboid glossitis Candida-associated.New phosphated poly(methyl methacrylate) polymers for the prevention of denture-induced microbial infection: an in vitro study.Antifungal Susceptibility Testing with Etest for Candida Species Isolated from Patients with Oral Candidiasis.Highly-active antiretroviral therapy and oral opportunistic microorganisms in HIV-positive individuals of Thailand.Markers of potential malignancy in chronic hyperplastic candidiasis.Carbohydrate Derived Fulvic Acid: An in vitro Investigation of a Novel Membrane Active Antiseptic Agent Against Candida albicans BiofilmsIn vitro activities of new triazole antifungal agents, posaconazole and voriconazole, against oral Candida isolates from patients suffering from denture stomatitis.
P2860
Q27009285-B04DFE1A-8212-44A5-8F40-51E777DD3455Q28067438-14358102-DDB3-436B-A299-A5A38F1599C3Q28087186-4CD68CB2-3BE3-40E4-AFE7-1C665FCAC51CQ28545844-AE6BFBA4-3421-44C8-9C66-C28609BEB57BQ33594425-41C3A4D0-7982-4E6E-8072-4A5ABA13113BQ33752749-3BB074FE-A630-4F0B-AB04-D61423F6FDC2Q34083917-1E52214A-37F4-4FB4-BD16-D51BA4382E4CQ34202383-E0832930-28F2-43D0-89B2-BAFF32614A28Q34208952-8963A083-DFB8-4193-9604-0E2CE3152342Q34295136-D41C03AA-D113-4117-906B-D06A9A4650C7Q34668042-75DDE208-BBB7-4F35-A03B-91E3C499E0DDQ35175064-34A273D5-1DDD-43A7-8DB5-057D545E2483Q35175626-21D63CF5-6741-4371-AC6C-0F5494BBD286Q35187151-091122A5-A9E8-48FF-9547-A3CCBB159568Q35616063-7B3F4E74-7E32-4942-9E6A-8A358C642D0AQ35684157-5D027A7F-C41D-4AC1-9B26-99D8758FAF4AQ35866679-82577F8A-6252-492E-BB57-A2C9753BD7F4Q35981210-C8974B9F-9D23-4AC2-9CA2-E83623DC16C9Q35988608-23512AFA-C6D7-46DD-BE3F-30003C596CF6Q36156146-5DEBB93B-F3A3-4F13-AFBD-0916E4B6AA16Q36205057-90F7A478-A781-4865-BDCD-D7C8E5A5533DQ36352384-C9A6F61F-12BD-42D9-A9EF-3156234C8091Q36756072-3394F0E0-99EE-439D-99F1-5E40508268C3Q36926992-953EA346-DA77-422E-94DD-D3DA7D48984DQ37850483-9539AEC8-F9D6-45C8-93D5-3CB43D494E88Q38068170-F29ADCAF-40AD-4240-BAB4-5814607DBDF1Q38139093-48FF6BAF-E87A-43C4-BAD6-B8C82B976DCDQ38261303-94EE41E2-727E-407E-A7E3-7F52995A79C8Q38363105-38EFB772-A621-4708-B5D8-AC6D58C2C03FQ38604392-841D4F51-44CD-4499-818F-8B8F7BDA5127Q38670904-1A9E3DCB-3B6D-441E-A5E4-A87C64AFD9C8Q38857865-678DA85C-715C-4957-99A4-385A9567F9B2Q39618454-987FA2A6-016E-4C72-8B5A-114F8FA8275CQ40595634-EB3B84A6-0B1E-4456-A763-4CDB32D2F7C2Q40648744-D39F369C-C494-4530-B813-9670E7CDE0FAQ41519513-3CC63F7C-3ED5-4202-BC87-B659F672DF3AQ41583479-8B4F40DF-E7D4-40F0-B96D-3884CBBE5172Q42504665-8EB79951-8149-45CB-9EC4-9BE8D83C40F6Q42563149-AE643996-BAFD-4043-8AF6-604756755C8CQ42727587-D6237612-71B4-48EC-B3DE-60CB102DA43B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Oral mucosal fungal infections.
@en
Oral mucosal fungal infections.
@nl
type
label
Oral mucosal fungal infections.
@en
Oral mucosal fungal infections.
@nl
prefLabel
Oral mucosal fungal infections.
@en
Oral mucosal fungal infections.
@nl
P2860
P1433
P1476
Oral mucosal fungal infections
@en
P2093
Lijian Jin
W Keung Leung
P2860
P356
10.1111/J.1600-0757.2008.00291.X
P577
2009-02-01T00:00:00Z